Key result
Bromocriptine mesylate yields rapid recovery from neuroleptic malignant syndrome in a single case report.
Why the study?
Neuroleptic malignant syndrome is a relatively uncommon, potentially lethal syndrome with limited success from usual treatments and high mortality.
Does bromocriptine successfully treat neuroleptic malignant syndrome?
Population
2 patients with neuroleptic malignant syndrome
Comparison
Bromocriptine mesylate vs usual medical intensive care unit treatment
Design
Case report
Authors
Loading...
Single-case success with bromocriptine does not change practice; leaves open its role in neuroleptic malignant syndrome.
Case Report (n=2)
Does bromocriptine successfully treat neuroleptic malignant syndrome?
First reported successful use of bromocriptine mesylate for the treatment of neuroleptic malignant syndrome.
P. S. Mueller (1983) conducted a case report in Neuroleptic malignant syndrome (n=2). Bromocriptine mesylate vs. Usual care was evaluated on Successful treatment. Bromocriptine mesylate was rapidly successful in treating a patient with neuroleptic malignant syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: